Driving Innovation in Breast Cancer (Breast Cancer Startup Challenge) graphic.
Monday, December 30, 2013

By Karen Surabian, Thomas Stackhouse, and Rose Freel, Contributing Writers, and Rosemarie Truman, Guest Writer

The National Cancer Institute (NCI), led by the Technology Transfer Center (TTC),  the Avon Foundation, and The Center for Advancing Innovation have partnered to create a “first-of-a-kind” Breast Cancer Start-up Challenge.

NCI, Leidos, and DMS logos.
Thursday, December 26, 2013

Forty-nine people joined the facility in September and October 2013.

The National Cancer Institute welcomes…

Aamir Akram
Clarissa Alexander
Robert Buckheit
Brian Chan
Kelly Dempsey
Christopher Descalzi
Ahmed Fahim
Devikala Gurusamy
Jaewoo Hong
Rhushikesh Kulkarni
James Shaum
Dionysios Watson
Yuheng Xi
Yi Xiang
Thomas Zengeya

Oil painting of William Shakespeare.
Thursday, December 26, 2013

By Ken Michaels, Guest Writer

In Shakepeare’s play “Hamlet,” Polonius inquires of the prince, “What do you read, my lord?” Not at all pleased with what he’s reading, Hamlet replies, “Words, words, words.”1

I have previously described the communication model in which a sender encodes a message and then sends it via some channel (or medium) to a receiver, who decodes the message and, ideally, understands what was sent. Surely the most common way of encoding a message is in choosing the most appropriate words for the listener or reader.

Women practicing yoga.
Friday, December 20, 2013

By Zack Howard, Guest Writer

In these uncertain times, when work can be stressful, disquieting, or downright upsetting, taking an hour on Thursday evenings to work out job- and life-induced twists can provide a welcome element of serenity.

Portrait photo of Terry Van Dyke
Monday, November 25, 2013

By Frank Blanchard, Staff Writer

Scientists at NCI and Frederick National Laboratory for Cancer Research (FNLCR) are partnering with the Lustgarten Foundation to test whether a vitamin D derivative will make a difference when combined with a conventional anticancer drug in treating tumors of the pancreas.

Pages